Transmembrane domain determinants of CD4 downregulation by HIV-1 Vpu

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 757-772

  Magadán, Javier G ^a   Bonifacino, Juan S ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MULTIPROTEIN COMPLEX; TRP22 PROTEIN; UNCLASSIFIED DRUG; VCP UFD1L NPL4 DISLOCASE COMPLEX; VPU PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; GOLGI COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; TRANSMEMBRANE DOMAIN; UBIQUITINATION;

AMINO ACID SEQUENCE; ANTIGENS, CD4; CELL LINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; UBIQUITINATION; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856946718     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05933-11     Document Type: Article

References (87)

1. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864.
2. Andrew AJ, Miyagi E, Strebel K. 2011. Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin. J. Virol. 85:2611-2619.
3. Arganaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J. 2003. Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J. Biol. Chem. 278:33912-33919.
4. Arien KK, et al. 2005. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79:8979-8990.
5. Belaidouni N, Marchal C, Benarous R, Besnard-Guerin C. 2007. Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein. Biochem. Biophys. Res. Commun. 357:688-693.
6. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR. 1993. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177: 1561-1566.
7. Binette J, et al. 2007. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4:75.
8. Bonifacino JS, Cosson P, Klausner RD. 1990. Colocalized transmembrane determinants for ER degradation and subunit assembly explain the intracellular fate of TCR chains. Cell 63:503-513.
9. Bonifacino JS, Dell'Angelica EC. 2001. Immunoprecipitation. Curr. Protoc. Cell Biol. 7:Unit 7.2.
10. Bonifacino JS, Suzuki CK, Klausner RD. 1990. A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science 247:79-82.
11. Bour S, Schubert U, Strebel K. 1995. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69: 1510-1520.
12. Bresnahan PA, Yonemoto W, Greene WC. 1999. SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for downregulation of CD4. J. Immunol. 163:2977-2981.
13. Buonocore L, Turi TG, Crise B, Rose JK. 1994. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204:482-486.
14. Burtey A, et al. 2007. Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane. Traffic 8:61-76.
15. Butticaz C, Michielin O, Wyniger J, Telenti A, Rothenberger S. 2007. Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 downmodulation. J. Virol. 81:1502-1505.
16. Chaudhuri R, Lindwasser OW, Smith WJ, Hurley JH, Bonifacino JS. 2007. Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J. Virol. 81:3877-3890.
17. Chaudhuri R, Mattera R, Lindwasser OW, Robinson MS, Bonifacino JS. 2009. A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex. J. Virol. 83:2518-2530.
18. Cosson P, Bonifacino JS. 1992. Role of transmembrane domain interactions in the assembly of class II MHC molecules. Science 258:659-662.
19. Craig HM, Reddy TR, Riggs NL, Dao PP, Guatelli JC. 2000. Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 271:9-17.
20. daSilva LL, et al. 2009. Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway. J. Virol. 83: 6578-6590.
21. Dube M, et al. 2009. Suppression of tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 83:4574-4590.
22. Ewart GD, Sutherland T, Gage PW, Cox GB. 1996. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70:7108-7115.
23. Fujiki Y, Hubbard AL, Fowler S, Lazarow PB. 1982. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J. Cell Biol. 93:97-102.
24. Greenberg ME, et al. 1997. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 downregulation. EMBO J. 16:6964-6976.
25. Guatelli JC. 2009. Interactions of viral protein U (Vpu) with cellular factors. Curr. Top. Microbiol. Immunol. 339:27-45.
26. Hoxie JA, et al. 1986. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234:1123-1127.
27. Hughes EA, Hammond C, Cresswell P. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. U. S. A. 94:1896-1901.
28. Huppa JB, Ploegh HL. 1997. The alpha chain of the T cell antigen receptor is degraded in the cytosol. Immunity 7:113-122.
29. Hussain A, Das SR, Tanwar C, Jameel S. 2007. Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein-a genetic, biochemical and biophysical analysis. Virol. J. 4:81.
30. Jin YJ, et al. 2005. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J. Immunol. 175:3157-3164.
31. Kim S, et al. 2005. Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 102:14278-14283.
32. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67.
33. Korber B, et al. 2000. Timing the ancestor of the HIV-1 pandemic strains. Science 288:1789-1796.
34. Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S. 1988. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 334:530-532.
35. Lee RJ, et al. 2004. Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J. 23: 2206-2215.
36. Lenburg ME, Landau NR. 1993. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:7238-7245.
37. Li Q, et al. 2010. Transmembrane segments prevent surface expression of sodium channel Nav1.8 and promote calnexin-dependent channel degradation. J. Biol. Chem. 285:32977-32987.
38. Lindwasser OW, Chaudhuri R, Bonifacino JS. 2007. Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr. Mol. Med. 7:171-184.
39. Lindwasser OW, et al. 2008. A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J. Virol. 82:1166-1174.
40. Lu JX, Sharpe S, Ghirlando R, Yau WM, Tycko R. 2010. Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci. 19:1877-1896.
41. MacKenzie KR, Prestegard JH, Engelman DM. 1997. A transmembrane helix dimer: structure and implications. Science 276:131-133.
42. Magadan JG, et al. 2010. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 6:e1000869.
43. Mahalakshmi R, Sengupta A, Raghothama S, Shamala N, Balaram P. 2005. Tryptophan-containing peptide helices: interactions involving the indole side chain. J. Pept. Res. 66:277-296.
44. Maldarelli F, Chen MY, Willey RL, Strebel K. 1993. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67:5056-5061.
45. Malim MH, Emerman M. 2008. HIV-1 accessory proteins- ensuring viral survival in a hostile environment. Cell Host Microbe 3:388-398.
46. Manolios N, Bonifacino JS, Klausner RD. 1990. Transmembrane helical interactions and the assembly of the T cell receptor complex. Science 249: 274-277.
47. Margottin F, et al. 1996. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation. Virology 223:381-386.
48. Margottin F, et al. 1998. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1:565-574.
49. Mayer TU, Braun T, Jentsch S. 1998. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J. 17:3251-3257.
50. Mehnert T, et al. 2008. Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism. Proteins 70:1488-1497.
51. Molinari M, Galli C, Piccaluga V, Pieren M, Paganetti P. 2002. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J. Cell Biol. 158: 247-257.
52. Monera OD, Sereda TJ, Zhou NE, Kay CM, Hodges RS. 1995. Relationship of sidechain hydrophobicity and alpha-helical propensity on the stability of the single-stranded amphipathic alpha-helix. J. Pept. Sci. 1:319-329.
53. Nethe M, Berkhout B, van der Kuyl AC. 2005. Retroviral superinfection resistance. Retrovirology 2:52.
54. Nguyen KL, et al. 2004. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Revindependent expression. Virology 319:163-175.
55. Park SH, De Angelis AA, Nevzorov AA, Wu CH, Opella SJ. 2006. Three-dimensional structure of the transmembrane domain of Vpu from HIV-1 in aligned phospholipid bicelles. Biophys. J. 91:3032-3042.
56. Park SH, et al. 2003. Three-dimensional structure of the channel-forming trans-membrane domain of virus protein "u" (Vpu) from HIV-1. J. Mol. Biol. 333:409-424.
57. Raja NU, Vincent MJ, M abdul Jabbar. 1994. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4. Virology 204:357-366.
58. Rapoport TA. 2007. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature 450:663-669.
59. Ray N, Doms RW. 2006. HIV-1 coreceptors and their inhibitors. Curr. Top. Microbiol. Immunol. 303:97-120.
60. Rhee SS, Marsh JW. 1994. Human immunodeficiency virus type 1 Nefinduced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68:5156-5163.
61. Ruiz A, Guatelli JC, Stephens EB. 2010. The Vpu protein: new concepts in virus release and CD4 down-modulation. Curr. HIV Res. 8:240-252.
62. Salmon P, et al. 1988. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J. Exp. Med. 168:1953-1969.
63. Schubert U, et al. 1998. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72: 2280-2288.
64. Schubert U, et al. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.
65. Senes A, Ubarretxena-Belandia I, Engelman DM. 2001. The Calpha- H... Ohydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc. Natl. Acad. Sci. U. S. A. 98:9056-9061.
66. Sereda TJ, Mant CT, Sonnichsen FD, Hodges RS. 1994. Reversed-phase chromatography of synthetic amphipathic alpha-helical peptides as a model for ligand/receptor interactions. Effect of changing hydrophobic environment on the relative hydrophilicity/hydrophobicity of amino acid side-chains. J. Chromatogr. A 676:139-153.
67. Sharpe HJ, Stevens TJ, Munro S. 2010. A comprehensive comparison of transmembrane domains reveals organelle-specific properties. Cell 142: 158-169.
68. Sharpe S, Yau WM, Tycko R. 2006. Structure and dynamics of the HIV-1 Vpu transmembrane domain revealed by solid-state NMR with magicangle spinning. Biochemistry 45:918-933.
69. Skasko M, et al. 2011. BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology 411:65-77.
70. Swanton E, High S, Woodman P. 2003. Role of calnexin in the glycanindependent quality control of proteolipid protein. EMBO J. 22: 2948-2958.
71. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
72. Tifft CJ, Proia RL, Camerini-Otero RD. 1992. The folding and cell surface expression of CD4 requires glycosylation. J. Biol. Chem. 267: 3268-3273.
73. Tiganos E, et al. 1998. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein. Virology 251:96-107.
74. Tsai YC, Weissman AM. 2011. Ubiquitylation in ERAD: reversing to go forward? PLoS Biol. 9:e1001038.
75. Varthakavi V, et al. 2006. The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic 7:298-307.
76. Vembar SS, Brodsky JL. 2008. One step at a time: endoplasmic reticulumassociated degradation. Nat. Rev. Mol. Cell Biol. 9:944-957.
77. Vigan R, Neil SJ. 2010. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J. Virol. 84:12958-12970.
78. Vincent MJ, Raja NU, Jabbar MA. 1993. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67:5538-5549.
79. Willey RL, Maldarelli F, Martin MA, Strebel K. 1992. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:7193-7200.
80. Wimley WC, White SH. 1996. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3:842-848.
81. Wittlich M, Thiagarajan P, Koenig BW, Hartmann R, Willbold D. 2010. NMR structure of the transmembrane and cytoplasmic domains of human CD4 in micelles. Biochim. Biophys. Acta 1798:122-127.
82. Wolfe MS, Kopan R. 2004. Intramembrane proteolysis: theme and variations. Science 305:1119-1123.
83. Yang M, Omura S, Bonifacino JS, Weissman AM. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187:835-846.
84. Yau WM, Wimley WC, Gawrisch K, White SH. 1998. The preference of tryptophan for membrane interfaces. Biochemistry 37:14713-14718.
85. Ye Y, Meyer HH, Rapoport TA. 2003. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162:71-84.
86. Ye Y, Rape M. 2009. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 10:755-764.
87. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA. 2004. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429:841-847.